Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enoxaparin with Docetaxel and Liposomal Doxorubicin in Advanced Pancreatic Cancer
NCT00426127Phase 2Terminated
- Sponsor
- University of Iowa
- Start
- Nov 2006
- Primary completion
- Jan 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of enoxaparin in pancreatic cancer (PC), sponsored by University of Iowa. Started Nov 2006; status: terminated.
02
Drugs
enoxaparin
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT00426127.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00426127.